• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清氨基酸水平升高诱导胰岛α细胞亚群启动胰腺神经内分泌肿瘤的形成。

Elevated Serum Amino Acids Induce a Subpopulation of Alpha Cells to Initiate Pancreatic Neuroendocrine Tumor Formation.

机构信息

Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA.

University Hospital Tübingen, Internal Medicine VIII, Tübingen 72076, Germany.

出版信息

Cell Rep Med. 2020 Aug 25;1(5):100058. doi: 10.1016/j.xcrm.2020.100058.

DOI:10.1016/j.xcrm.2020.100058
PMID:33205067
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7659536/
Abstract

The cellular origin of sporadic pancreatic neuroendocrine tumors (PNETs) is obscure. Hormone expression suggests that these tumors arise from glucagon-producing alpha cells or insulin-producing β cells, but instability in hormone expression prevents linage determination. We utilize loss of hepatic glucagon receptor (GCGR) signaling to drive alpha cell hyperproliferation and tumor formation to identify a cell of origin and dissect mechanisms that drive progression. Using a combination of genetically engineered knockout mice and GCGR-inhibiting antibodies, we show that elevated plasma amino acids drive the appearance of a proliferative population of SLC38A5 embryonic progenitor-like alpha cells in mice. Further, we characterize tumors from patients with rare bi-allelic germline loss-of-function variants and find prominent tumor-cell-associated expression of the SLC38A5 paralog SLC7A8 as well as markers of active mTOR signaling. Thus, progenitor cells arise from adult alpha cells in response to metabolic signals and, when inductive signals are chronically present, drive tumor initiation.

摘要

散发性胰腺神经内分泌肿瘤(PNETs)的细胞起源尚不清楚。激素表达表明这些肿瘤来源于胰高血糖素产生的α细胞或胰岛素产生的β细胞,但激素表达的不稳定性阻止了谱系的确定。我们利用肝源性胰高血糖素受体(GCGR)信号的丧失来驱动α细胞的过度增殖和肿瘤形成,以确定起始细胞并剖析驱动进展的机制。我们使用基因工程敲除小鼠和 GCGR 抑制抗体的组合,表明升高的血浆氨基酸驱动 SLC38A5 胚胎祖细胞样α细胞的增殖群体在小鼠中出现。此外,我们对来自具有罕见双等位基因种系功能丧失变异的患者的肿瘤进行了表征,发现 SLC38A5 旁系物 SLC7A8 以及活跃的 mTOR 信号标志物在肿瘤细胞中显著表达。因此,祖细胞是在代谢信号的作用下从成熟的α细胞中产生的,而当诱导信号持续存在时,会驱动肿瘤的发生。

相似文献

1
Elevated Serum Amino Acids Induce a Subpopulation of Alpha Cells to Initiate Pancreatic Neuroendocrine Tumor Formation.血清氨基酸水平升高诱导胰岛α细胞亚群启动胰腺神经内分泌肿瘤的形成。
Cell Rep Med. 2020 Aug 25;1(5):100058. doi: 10.1016/j.xcrm.2020.100058.
2
Fibroblast growth factor 21 (FGF21) and glucagon-like peptide 1 contribute to diabetes resistance in glucagon receptor-deficient mice.成纤维细胞生长因子 21(FGF21)和胰高血糖素样肽 1 有助于缺乏胰高血糖素受体的小鼠抵抗糖尿病。
Diabetes. 2014 Jan;63(1):101-10. doi: 10.2337/db13-0710. Epub 2013 Sep 23.
3
Differential expression of glucagon and glucagon-like peptide 1 receptors in mouse pancreatic alpha and beta cells in two models of alpha cell hyperplasia.两种胰岛α细胞增生模型中鼠胰岛α和β细胞中胰高血糖素和胰高血糖素样肽 1 受体的差异表达。
Mol Cell Endocrinol. 2009 Nov 13;311(1-2):69-76. doi: 10.1016/j.mce.2009.07.024. Epub 2009 Jul 30.
4
Pancreatic neuroendocrine tumors in glucagon receptor-deficient mice.胰高血糖素受体缺陷小鼠中的胰腺神经内分泌肿瘤。
PLoS One. 2011;6(8):e23397. doi: 10.1371/journal.pone.0023397. Epub 2011 Aug 10.
5
Amino Acid Transporter Slc38a5 Controls Glucagon Receptor Inhibition-Induced Pancreatic α Cell Hyperplasia in Mice.氨基酸转运蛋白Slc38a5控制胰高血糖素受体抑制诱导的小鼠胰腺α细胞增生。
Cell Metab. 2017 Jun 6;25(6):1348-1361.e8. doi: 10.1016/j.cmet.2017.05.006.
6
The aromatic amino acid sensor GPR142 controls metabolism through balanced regulation of pancreatic and gut hormones.芳香族氨基酸传感器 GPR142 通过平衡调节胰腺和肠道激素来控制代谢。
Mol Metab. 2019 Jan;19:49-64. doi: 10.1016/j.molmet.2018.10.012. Epub 2018 Nov 5.
7
Glucagon Potentiates Insulin Secretion Via β-Cell GCGR at Physiological Concentrations of Glucose.在生理浓度的葡萄糖条件下,胰高血糖素通过β细胞 GCGR 增强胰岛素分泌。
Cells. 2021 Sep 21;10(9):2495. doi: 10.3390/cells10092495.
8
Liver-specific disruption of the murine glucagon receptor produces α-cell hyperplasia: evidence for a circulating α-cell growth factor.肝脏特异性敲除小鼠胰高血糖素受体导致α细胞增生:循环α细胞生长因子的证据。
Diabetes. 2013 Apr;62(4):1196-205. doi: 10.2337/db11-1605. Epub 2012 Nov 16.
9
Dapagliflozin promotes beta cell regeneration by inducing pancreatic endocrine cell phenotype conversion in type 2 diabetic mice.达格列净通过诱导 2 型糖尿病小鼠胰腺内分泌细胞表型转化促进β细胞再生。
Metabolism. 2020 Oct;111:154324. doi: 10.1016/j.metabol.2020.154324. Epub 2020 Jul 23.
10
GLP-2 receptor signaling controls circulating bile acid levels but not glucose homeostasis in Gcgr mice and is dispensable for the metabolic benefits ensuing after vertical sleeve gastrectomy.GLP-2 受体信号通路控制循环胆汁酸水平,但不影响 Gcgr 小鼠的葡萄糖稳态,且对于垂直袖状胃切除术(VSG)后产生的代谢益处并非必需。
Mol Metab. 2018 Oct;16:45-54. doi: 10.1016/j.molmet.2018.06.006. Epub 2018 Jun 9.

引用本文的文献

1
Glucagon and Glucose Availability Influence Metabolic Heterogeneity and Malignancy in Pancreatic Neuroendocrine Tumour (pNET) Cells: Novel Routes for Therapeutic Targeting.胰高血糖素和葡萄糖可用性影响胰腺神经内分泌肿瘤(pNET)细胞的代谢异质性和恶性程度:治疗靶点的新途径
Molecules. 2025 Jun 25;30(13):2736. doi: 10.3390/molecules30132736.
2
Metabolic changes in neuroendocrine neoplasms.神经内分泌肿瘤中的代谢变化。
Cell Mol Life Sci. 2025 May 16;82(1):205. doi: 10.1007/s00018-025-05656-2.
3
Hepatic PKA Mediates Liver and Pancreatic α-Cell Cross Talk.

本文引用的文献

1
Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors.增强子特征可对无功能胰腺神经内分泌肿瘤的结局进行分层和预测。
Nat Med. 2019 Aug;25(8):1260-1265. doi: 10.1038/s41591-019-0493-4. Epub 2019 Jul 1.
2
Increased SLC38A4 Amino Acid Transporter Expression in Human Pancreatic α-Cells After Glucagon Receptor Inhibition.胰高血糖素受体抑制后人类胰腺 α 细胞中 SLC38A4 氨基酸转运蛋白表达增加。
Endocrinology. 2019 May 1;160(5):979-988. doi: 10.1210/en.2019-00022.
3
Efficacy and Safety of Everolimus plus Somatostatin Analogues in Patients with Neuroendocrine Tumors.
肝脏蛋白激酶A介导肝脏与胰腺α细胞间的相互作用。
Diabetes. 2025 Jun 1;74(6):885-897. doi: 10.2337/db24-0958.
4
Absence of PNET formation and normal longevity in a mouse model of Mahvash disease.马瓦什病小鼠模型中无原始神经外胚层肿瘤形成且寿命正常。
Heliyon. 2024 Jul 26;10(15):e35362. doi: 10.1016/j.heliyon.2024.e35362. eCollection 2024 Aug 15.
5
Glutamine addiction and therapeutic strategies in pancreatic cancer.胰腺癌中的谷氨酰胺成瘾与治疗策略
World J Gastrointest Oncol. 2023 Nov 15;15(11):1852-1863. doi: 10.4251/wjgo.v15.i11.1852.
6
SLC38A5 Modulates Ferroptosis to Overcome Gemcitabine Resistance in Pancreatic Cancer.SLC38A5 调节铁死亡以克服胰腺癌对吉西他滨的耐药性。
Cells. 2023 Oct 23;12(20):2509. doi: 10.3390/cells12202509.
7
Amino acid transporter SLC38A5 is a tumor promoter and a novel therapeutic target for pancreatic cancer.氨基酸转运蛋白 SLC38A5 是胰腺癌的肿瘤促进剂和新的治疗靶点。
Sci Rep. 2023 Oct 6;13(1):16863. doi: 10.1038/s41598-023-43983-1.
8
Hyperaminoacidemia induces pancreatic α cell proliferation via synergism between the mTORC1 and CaSR-Gq signaling pathways.高氨基酸血症通过 mTORC1 和 CaSR-Gq 信号通路的协同作用诱导胰腺 α 细胞增殖。
Nat Commun. 2023 Jan 16;14(1):235. doi: 10.1038/s41467-022-35705-4.
9
Advancing Cancer Treatment by Targeting Glutamine Metabolism-A Roadmap.通过靶向谷氨酰胺代谢推进癌症治疗——路线图
Cancers (Basel). 2022 Jan 22;14(3):553. doi: 10.3390/cancers14030553.
10
SLC6A14 and SLC38A5 Drive the Glutaminolysis and Serine-Glycine-One-Carbon Pathways in Cancer.SLC6A14和SLC38A5驱动癌症中的谷氨酰胺分解和丝氨酸-甘氨酸-一碳途径。
Pharmaceuticals (Basel). 2021 Mar 4;14(3):216. doi: 10.3390/ph14030216.
依维莫司联合生长抑素类似物治疗神经内分泌肿瘤患者的疗效与安全性
J Cancer. 2018 Dec 10;9(24):4783-4790. doi: 10.7150/jca.25908. eCollection 2018.
4
Disruption of glucagon receptor signaling causes hyperaminoacidemia exposing a possible liver-alpha-cell axis.胰高血糖素受体信号通路的破坏导致高氨基酸血症,揭示了一种可能的肝-胰岛α细胞轴。
Am J Physiol Endocrinol Metab. 2018 Jan 1;314(1):E93-E103. doi: 10.1152/ajpendo.00198.2017. Epub 2017 Oct 3.
5
Interrupted Glucagon Signaling Reveals Hepatic α Cell Axis and Role for L-Glutamine in α Cell Proliferation.中断的胰高血糖素信号揭示肝脏α细胞轴及L-谷氨酰胺在α细胞增殖中的作用。
Cell Metab. 2017 Jun 6;25(6):1362-1373.e5. doi: 10.1016/j.cmet.2017.05.011.
6
Amino Acid Transporter Slc38a5 Controls Glucagon Receptor Inhibition-Induced Pancreatic α Cell Hyperplasia in Mice.氨基酸转运蛋白Slc38a5控制胰高血糖素受体抑制诱导的小鼠胰腺α细胞增生。
Cell Metab. 2017 Jun 6;25(6):1348-1361.e8. doi: 10.1016/j.cmet.2017.05.006.
7
Whole-genome landscape of pancreatic neuroendocrine tumours.胰腺神经内分泌肿瘤的全基因组图谱。
Nature. 2017 Mar 2;543(7643):65-71. doi: 10.1038/nature21063. Epub 2017 Feb 15.
8
Single cell transcriptomic profiling of mouse pancreatic progenitors.小鼠胰腺祖细胞的单细胞转录组分析
Physiol Genomics. 2017 Feb 1;49(2):105-114. doi: 10.1152/physiolgenomics.00114.2016. Epub 2016 Dec 23.
9
Pancreatic α-cell hyperplasia and hyperglucagonemia due to a glucagon receptor splice mutation.由于胰高血糖素受体剪接突变导致的胰腺α细胞增生和高胰高血糖素血症。
Endocrinol Diabetes Metab Case Rep. 2016;2016. doi: 10.1530/EDM-16-0081. Epub 2016 Nov 21.
10
Peptide Receptor Radionuclide Therapy Outcomes in a North American Cohort With Metastatic Well-Differentiated Neuroendocrine Tumors.北美转移性高分化神经内分泌肿瘤队列中的肽受体放射性核素治疗结果
Pancreas. 2017 Feb;46(2):151-156. doi: 10.1097/MPA.0000000000000734.